Drug Shortage Report for ACT DILTIAZEM CD

Last updated on 2018-10-11 History
Report ID 61340
Drug Identification Number 02370654
Brand name ACT DILTIAZEM CD
Common or Proper name DILTIAZEM CD
Company Name TEVA CANADA LIMITED
Active Ingredient(s) DILTIAZEM HYDROCHLORIDE
Strength(s) 300MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 100
ATC code C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-09-12
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2018-10-11
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2018-10-11 French Compare
v4 2018-10-11 English Compare
v3 2018-09-13 English Compare
v2 2018-09-12 French Compare
v1 2018-09-12 English Compare